OncoLens, an Atlanta-based SaaS platform dedicated to streamlining the planning of cancer treatment, has announced the closing of a $2.5M pre-Series A funding round led by BIP Capital. Atlanta Technology Angels and the Robbins Fund also participated in the round; all three had previously invested in OncoLens’